secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aurinia Pharmaceuticals Inc. (AUPH)
CIK:        0001600620
Form:       8-K
Filed at:   2023-07-03T23:59:59+00:00
Accession:  0001600620-23-000027
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aurinia board explores strategic alternatives including sale; two directors resign after vote shortfall
--------------------------------------------------------------------------------

- Board initiated exploration of strategic alternatives including sale, merger, or other transaction.
- Retained JP Morgan as financial advisor; Skadden Arps and Borden Ladner Gervais as legal counsel.
- Directors George Milne and Joseph Hagan resigned effective June 29 after less-than-majority support at AGM.
- Korn Ferry engaged to search for two new board members.
- No timetable set; no assurance of any transaction outcome.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1600620/000160062023000027/0001600620-23-000027-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1600620/000160062023000027/auph-20230629.htm
  HTML page:      https://secwatch.observer/filing/0001600620-23-000027

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer